Limitations, agreements, and source contact

Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma · Source last updated 2017-12-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

chuff1@jhmi.edu

organization

Johns Hopkins University

phone

410-955-8842

title

Dr. Carol Ann Huff

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice